Frontiers in neuroscience · 2023
Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Smieszek Sandra P, Kaden Alyssa R, Johnson Caroline E, Brzezynski Jennifer L, Xiao Changfu, Polymeropoulos Christos M, Birznieks Gunther, Emsellem Helene A, Polymeropoulos Mihael H
Аннотация
UNLABELLED: We present a case of an adult female diagnosed with Delayed Sleep-Wake Phase Disorder (DSWPD) and Optic Nerve Hypoplasia (ONH), with a confirmed delayed Dim Light Melatonin Onset (DLMO), who reports the inability to fall asleep at their desired bedtime and obtain adequate sleep nightly, despite the ability to have a full night's sleep when not required to be up at a specific time for societal requirements. The participant was enrolled in an 11-month Open-Label Extension (OLE) following the randomized portion of a clinical study and was successfully treated with tasimelteon. DSWPD symptoms were resolved, and their previously delayed sleep-wake cycle was advanced.
CLINICAL TRIAL REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT04652882, identifier NCT04652882.
CLINICAL TRIAL REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT04652882, identifier NCT04652882.